Owkin is a medical treatment and therapeutics company founded by Thomas Clozel. They develop artificial intelligence and machine learning tools to augment and develop medical and biological research.

Owkin is a developer of machine learning tools designed to augment medical and biological research. The company's tool integrates biomedical images, genomics and clinical data in order to discover mechanisms and biomarkers associated with diseases and treatment outcomes and build models that are as interpretable as possible, for an understanding of the initial data and, through transfer learning, they push the intelligence of pre-trained algorithms into new models, enabling cohorts to have a data-based predictive model.

Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology and Gilles Wainrib, PhD, a pioneer in the field of Artificial Intelligence in biology.

Owkin develops scientific collaborations with medical institutions and partners with pharmaceutical companies. Through these partnerships, Owkin has developed a federated learning technology in healthcare to overcome the data sharing problem, building collective intelligence from distributed data at scale while preserving data privacy and security.


Owkin Socrates

Owkin Socrates is Owkin's technology platform. Socrates is engineered to be usable by non machine learning experts to perform artificial intelligence projects and deliver production level predictive models. With the models, users can develop drug development stages, from survival prognosis to target discovery, patient recruitment for clinical trials to post-market analysis.

The Owkin Socrates platform is powered by machine learning and deep learning algorithms.

Owkin Services

Owkin provides their experience in artificial intelligence and machine learning to their partners to help their partners research and development skills for existing and future data analytics. The services include data science, technology assessments, specific target and molecule discover projects and real-world data for clinical trial optimization.



Owkin announced the close of their seed round on October 30, 2016 with a raised total of $2.1 million. Participation in the round came from Shana Fisher, Nicole Junkermann, NJF Capital, Jorg Mohaupt, Jean-Paul Clozel and Brent Hoberman.

Series A

Owkin announced the first close of their Series A financing on January 16, 2018 with a raised total of $11 million. Otium Capital led the round, which included participation from Plug and Play, NJF Capital and Cathay Innovation.

Owkin announce the second close of their Series A financing on May 23, 2018 with a raised total of $5 million from GV.

On March 7, 2019 Owkin announced the close of an undisclosed funding round with an undisclosed raised amount. F-Prime led the financing round, which included participation from NJF Capital, GV, Eight Roads Ventures and Cathay Innovation.


December 3, 2019

Partnership aims to connect UK hospitals with AI 'federated learning'

December 2, 2019

Owkin, NVIDIA team up to deliver AI to hospitals

October 7, 2019

Owkin Publishes Research in Nature Medicine

October 7, 2019

Owkin's mesothelioma AI discovers new biomarkers from lung biopsy images

December 14, 2018

OWKIN announces an AI-powered medical research network.

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

December 13, 2018

Owkin launches global patient data sharing network for training AIs

Earlier this year, the New York-based Owkin raised about $16 million through a series A funding round led by Otium Venture.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Owkin funding round, January 2018
Series A round
January 2018
Otium Capital
Owkin funding round, March 2019
March 2019
F-Prime Capital Partners
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine



Adrian Gonzalez Lopez

Chief Technology Officer

Alberto Romagnoni, PhD

Translational Research Scientist

Ali Bouarab

Lead Devops

Alicia Simion

Employee Experience Manager

Amandine Lagorce

Partnership Manger

Andre Manoel, PhD

Machine Learning Scientist

Anna Bondarekno

Chief Operating Officer

Anna Huyghues-Despointes

Head of Strategy

Beniot Schmauch, PhD

Senior Data Scientist

Bruno Raillard

Board member

Camille Marini, PhD

Vice President of Engineering

Cedric Whitney


Cedric Whitney

Senior Partnership Manager

Charles Maussion

Data Scientist

Charlie Saillard

Data Scientist

Chloe Simpson

Data Scientist

Christophe Lecointe

Back-End Developer

Claire Philippe

Substra Senior Project Manager

Clement Gautier

Substra Devops Engineer

Corine Bardak

General Accountant

David Cahane

Head of Pharma Research and Development Projects

David Vallas

Legal Counsel

Derek T. Russell-Kraft


Elodie Pronier, PhD

Translational Research Scientist

Eric Tramel, PhD

Group Lead, Federated Learning

Page 1 of 4

Further reading


Documentaries, videos and podcasts


Using Artificial Intelligence to make accurate medical predictions? Meet Owkin (Startup Spotlights)

November 30, 2018




Jonathan Shieber
May 8, 2020
Imagine a model of collaborative research and development among hospitals, pharmaceutical companies, universities and other research institutions where no one shared any actual data. That's the dream of the new New York-based startup Owkin, which has raised $25 million in fresh financing from investors including Bpifrance Large Venture, Cathay Innovation and MACSF (the French Pension Fund [...]


Page 1 of 2
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.